An exciting opportunity for a healthcare data scientist – the post holder will support cross regional data analysis for a project which is enabling regional, acute hospital admissions data to support vaccine safety research. To enable surveillance and research on the COVID-19 vaccination programme and other rare events there is a critical need for rapid, near real time and more...
In an effort to encourage more young people to work for the NHS, Barts Life Sciences, a joint research programme led by Barts Health NHS Trust and Queen Mary University of London, have opened a new training facility for health care and life sciences in east London in partnership with Newham College. The facility – known as the Barts Health...
Barts Life Sciences is recruiting for a digital fellow for our programme of AI and machine learning projects, CAP-AI. This project, ThyrAI, will develop automatic interpretation of thyroid biopsy specimen slides for automated diagnosis using machine and deep learning approaches. Computer programs can then be devised for feature extraction from image data and feeding of this information to classifiers for...
Professors Claude Chelala and Louise Jones from Barts Cancer Institute, Queen Mary University of London, are part of a €21.3 million public-private research programme that will seek to use artificial intelligence (AI) to improve care for patients with prostate, breast and lung cancer. The aim of the research project, named OPTIMA (Optimal Treatment for Patients with Solid Tumours in Europe Through Artificial intelligence), is to design, develop and...
Queen Mary University of London professors Rakesh Uppal and Áine McKnight have been at the centre of a new clinical trial finding that pHOXWELL – a nasal spray developed by biotech company pHOXBIO – reduced SARS-CoV-2 infection by 63 per cent in the group given pHOXWELL compared to the group given the placebo. SARS-CoV-2 is the virus that causes Covid-19....
An exciting opportunity has arisen to work as part of our precision medicine team at Barts Life Sciences. More information and how to apply can be found here: http://jobs.bartshealth.nhs.uk/job/UK/London/London/Barts_Health_NHS_Trust/Administrative_Clerical/Administrative_Clerical-v3441257?_ts=24451 Closing date: 12th September
Thousands of diabetes patients could be spared a limb amputation thanks to ground-breaking AI technology that has helped Barts Life Sciences identify people at risk from complications. Clinicians at Barts Health NHS Trust, one of the largest trusts in the UK, say it would have taken a clinician over 100 years to review the volume of data analysed in a...
Clinithink artificial intelligence software takes just weeks to sift through data that would take a human more than a century – enabling quicker treatment that could save limbs The Clinithink software analysed 14.2 million medical records and notes to identify patients with diabetic foot disease. A new AI technology being trialled at a major NHS hosptial trust could transform treatment...
Barts Life Sciences and SEHTA are delighted to announce that Professor Sir Mark Caulfield, CEO of Barts Life Sciences will be the keynote speaker at the SEHTA 2021 International MedTech Expo & Conference. About the conference: Friday 8th October 2021, Hilton London Tower Bridge Hotel www.sehtamedtechexpo.co.uk The SME focused healthcare event driving collaborations between business, care, clinicians & academics Improving...
By Sophie Williams, Digital Pioneer Fellow Patient input is vital to medical research. Scientists need to hear about patient experiences to be sure that they are researching the most pressing questions. In a clinical trial the potential benefit of a new drug needs to be clearly explained to convince an individual to join the trial. But in data research the...
Accessibility options
Translate the page